Papaverine
Papaverine
Acino Pharma (Pty) Ltd
Every registration of this product has been cancelled.
Registration
- Applicant
- Acino Pharma (Pty) Ltd
- Registrations
- 1
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Papaverine 60 EACH VIAL CONTAINS PAPAVERINE HYDROCHLORIDE 60 mg | 60 | X0204X/7.1.5/204 | Cancelled | Not determined | None |
Regulatory status
This product is still scheduled by law even when this site could not determine which tier it falls under. The label carries the S number in a square border; ask a pharmacist if you need to know its schedule.
Listings for this ingredient that could not be applied to this product
S2: Papaverine
- substances, preparations and mixtures thereof.
Consolidated Schedules 06 July 2026, line 2488
2 of 2 approved products with this ingredient carry S6 on their leaflet.
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
1-[(3,4-Dimethoxyphenyl)methyl]-6,7-dimethoxyisoquinoline
Drag to rotate. Structure from PubChem CID 4680.
SAHPRA documents
SAHPRA has not published a professional information or patient information leaflet for this product.